Our Blogs, With Science We Believe In
Stay informed with news, articles, and key milestones
from PAEAN's research and development journey.
News Jan 06, 2026
Pian Biotechnology Launches World’s First Clinical Trial of Mitochondrial Therapy
World's first clinical trial of mitochondrial therapy…
Read More
News Jan 06, 2026
PN-101: Pioneering the Future of Mitochondria-Based Therapies
Pian Biotechnology’s PN-101 is set to redefine regenerative medicine as the first mitochondrial therapy entering clinical trials. Targeting the cellular powerhouses, PN-101 aims to restore energy production, improve cell function, and combat degenerative diseases.
Read More
News Jan 06, 2026
Global First: Mitochondrial Therapy Sets New Standard in Medicine
Pian Biotechnology’s PN-101 has become the first mitochondrial therapy to enter clinical trials, establishing a global precedent in regenerative medicine. The therapy targets mitochondrial dysfunction, which is a major factor in aging, neurodegeneration, and metabolic diseases.
Read More
Event Jan 06, 2026
Phase 1 Clinical Trial of PN-101 to Evaluate Safety and Efficacy
Pian Biotechnology has initiated a Phase 1 clinical trial for PN-101, the world’s first mitochondrial therapy. The trial focuses on assessing safety, tolerability, and preliminary efficacy in patients with degenerative diseases linked to mitochondrial dysfunction.
Read More
Event Jan 06, 2026
PN-101: How Pian Biotechnology’s Mitochondrial Therapy Works
Pian Biotechnology’s PN-101 represents a breakthrough in regenerative medicine, targeting mitochondrial dysfunction, a root cause of many degenerative diseases. PN-101 works by restoring mitochondrial function, enhancing energy production at the cellular level, and supporting overall cellular health.
Read More
News Jan 06, 2026
World’s First Clinical Trial of Mitochondrial Therapy by Pian Biotechnology
Pian Biotechnology has launched the world’s first clinical trial of a mitochondrial therapy, marking a historic milestone in regenerative medicine. The therapy, PN-101, is designed to restore mitochondrial function and enhance cellular energy metabolism, offering hope for patients with degenerative diseases.
Read More Headquarter : #108SB, DaeduckBiz Center
17 Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea
Mail : info@paeanbio.com
Phone : 042-334-7378 | Fax : 042-334-7096
Subscribe Our News
Copyrights © 2025 All Rights Reserved by PAEAN BIOTECHNOLOGY